Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Seminars in Oncology
|
November 29, 2015
MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms
Pui-Kei Wu, Jong-In Park
International Journal of Molecular Sciences
|
August 6, 2020
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
Pui-Kei Wu, Andrew Becker, Jong-In Park
International Journal of Molecular Sciences
|
December 24, 2021
eIF5A-Independent Role of DHPS in p21<sup>CIP1</sup> and Cell Fate Regulation
Andrew E Becker, Pui-Kei Wu, Jong-In Park
Cancer Letters
|
January 13, 2021
Mortalin depletion induces MEK/ERK-dependent and ANT/CypD-mediated death in vemurafenib-resistant B-Raf<sup>V600E</sup> melanoma cells
Pui-Kei Wu, Seung-Keun Hong, Jong-In Park
Molecular and Cellular Biology
|
July 5, 2017
Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in <i>KRAS</i> and <i>BRAF</i> Tumor Cells
Pui-Kei Wu, Seung-Keun Hong, Jong-In Park
Cellular Signalling
|
October 8, 2017
A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses
Seung-Keun Hong, Pui-Kei Wu, Jong-In Park
Cancer Biology & Therapy
|
May 6, 2017
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells
Dmytro Starenki, Seung-Keun Hong, Pui-Kei Wu, et al.
Cellular Signalling
|
July 13, 2015
ERK1/2 can feedback-regulate cellular MEK1/2 levels
Seung-Keun Hong, Pui-Kei Wu, Mansi Karkhanis, et al.
Cancer Biology & Therapy
|
October 28, 2016
Suppression of B-Raf<sup>V600E</sup> melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone
Seung-Keun Hong, Dmytro Starenki, Pui-Kei Wu, et al.
The FEBS Journal
|
February 3, 2015
Active ERK2 is sufficient to mediate growth arrest and differentiation signaling
Pui-Kei Wu, Seung-Keun Hong, Seung-Hee Yoon, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Seminars in Oncology
|
November 29, 2015
MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms
Pui-Kei Wu, Jong-In Park
International Journal of Molecular Sciences
|
August 6, 2020
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
Pui-Kei Wu, Andrew Becker, Jong-In Park
International Journal of Molecular Sciences
|
December 24, 2021
eIF5A-Independent Role of DHPS in p21<sup>CIP1</sup> and Cell Fate Regulation
Andrew E Becker, Pui-Kei Wu, Jong-In Park
Cancer Letters
|
January 13, 2021
Mortalin depletion induces MEK/ERK-dependent and ANT/CypD-mediated death in vemurafenib-resistant B-Raf<sup>V600E</sup> melanoma cells
Pui-Kei Wu, Seung-Keun Hong, Jong-In Park
Molecular and Cellular Biology
|
July 5, 2017
Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in <i>KRAS</i> and <i>BRAF</i> Tumor Cells
Pui-Kei Wu, Seung-Keun Hong, Jong-In Park
Cellular Signalling
|
October 8, 2017
A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses
Seung-Keun Hong, Pui-Kei Wu, Jong-In Park
Cancer Biology & Therapy
|
May 6, 2017
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells
Dmytro Starenki, Seung-Keun Hong, Pui-Kei Wu, et al.
Cellular Signalling
|
July 13, 2015
ERK1/2 can feedback-regulate cellular MEK1/2 levels
Seung-Keun Hong, Pui-Kei Wu, Mansi Karkhanis, et al.
Cancer Biology & Therapy
|
October 28, 2016
Suppression of B-Raf<sup>V600E</sup> melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone
Seung-Keun Hong, Dmytro Starenki, Pui-Kei Wu, et al.
The FEBS Journal
|
February 3, 2015
Active ERK2 is sufficient to mediate growth arrest and differentiation signaling
Pui-Kei Wu, Seung-Keun Hong, Seung-Hee Yoon, et al.
Page
of 3